Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Double-blind Placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients

NCT03464305 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT03464305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03464305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Double-blind Placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients
Lead sponsor
University Hospital, Antwerp
Phase
Phase 3
Overall status
Active, not recruiting
Start date
February 22, 2018
Completion date
December 31, 2027
Enrollment
148 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer